The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1365
New Treatments for Keratoconus
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Keratoconus is a fairly common, progressive, noninflammatory, corneal-thinning disorder in which the cornea has a conical shape. Rigid gas permeable (RGP) contact lenses or corneal transplantation are effective treatments, but intracorneal ring segments and collagen cross-linking procedures offer some new alternatives in the management of the disease.

THE DISEASE — Keratoconus has a variable presentation, ranging from myopic astigmatism requiring only spectacle correction to significant corneal stromal thinning, corneal protrusion, and corneal scarring requiring corneal transplantation. It has an incidence of 1 in 2000 and usually appears in puberty and progresses through the 3rd or 4th decade. Some studies have suggested an association with autoimmune disorders, but most patients have isolated bilateral keratoconus.

STANDARD TREATMENT — Management of early keratoconus generally begins with ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: New Treatments for Keratoconus
Article code: 1365d
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian